Literature DB >> 2645501

Urea synthesis, nitrogen balance, and glucose turnover in growth-hormone-deficient children before and after growth hormone administration.

W T Dahms1, R P Owens, S C Kalhan, D S Kerr, R K Danish.   

Abstract

We measured the effect of human growth hormone (hGH) on urea synthesis, nitrogen retention, and glucose turnover in ten euthyroid growth hormone (GH)-deficient children before and after seven daily injections of 0.1 U/kg hGH. The patients were fed a weight-maintaining diet with 9% of energy derived from protein. Following an overnight fast, urea synthesis and glucose turnover were determined using a primed constant infusion of [15N2] urea and a constant infusion of [6,6-2H2] glucose. Human growth hormone produced a decrease in urea nitrogen synthesis from 6.8 +/- 0.5 to 4.2 +/- 0.4 mg/kg.h; (P less than .01), while plasma urea nitrogen decreased from 13.1 +/- 0.8 to 7.4 +/- 0.8 mg/dL; (P less than .01). The decrease in urea synthesis was reflected in a corresponding decrease in urine urea nitrogen excretion (-2.8 mg/kg.h). There was a significant correlation between plasma urea nitrogen and urea synthesis rate both before (r = 0.85, P less than .01) and after (r = 0.79, P less than .01) hGH treatment. In response to hGH, there was a rise in both plasma glucose (81.4 +/- 2.2 v 89.8 +/- 2.3 mg/dL; P less than .05) and insulin (5.7 +/- 0.8 v 13.1 +/- 3.0 microU/mL; P less than .05), however, glucose turnover remained unchanged (4.7 +/- 0.3 v 4.6 +/- 0.6 mg/kg.min). After seven days of growth hormone treatment, the patients were placed on 0.1 U/kg of hGH three times a week for 6 months, and their growth rate was calculated.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2645501     DOI: 10.1016/0026-0495(89)90075-9

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  7 in total

1.  GH/IGF-I axis in severe systemic disorders.

Authors:  P De Feo
Journal:  J Endocrinol Invest       Date:  2002-06       Impact factor: 4.256

2.  Changes in body composition and energy expenditure after six weeks' growth hormone treatment.

Authors:  J W Gregory; S A Greene; R T Jung; C M Scrimgeour; M J Rennie
Journal:  Arch Dis Child       Date:  1991-05       Impact factor: 3.791

3.  In vivo nitrogen metabolism in ornithine transcarbamylase deficiency.

Authors:  M Yudkoff; Y Daikhin; I Nissim; A Jawad; J Wilson; M Batshaw
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

4.  The effect of human growth hormone therapy on L-(methyl-2H3)-leucine turnover and urinary pseudouridine concentration in patients with Ullrich-Turner syndrome.

Authors:  H Böhles; L Brendel; H Förster; K Träger; J Vogt; M Georgieff
Journal:  Eur J Pediatr       Date:  1996-04       Impact factor: 3.183

5.  Metabolic effects of growth hormone treatment: an early predictor of growth response?

Authors:  J W Gregory; S A Greene; R T Jung; C M Scrimgeour; M J Rennie
Journal:  Arch Dis Child       Date:  1993-02       Impact factor: 3.791

6.  In vivo measurement of ureagenesis with stable isotopes.

Authors:  M Yudkoff; Y Daikhin; X Ye; J M Wilson; M L Batshaw
Journal:  J Inherit Metab Dis       Date:  1998       Impact factor: 4.982

Review 7.  Renal effects of growth hormone. II. Electrolyte homeostasis and body composition.

Authors:  G D Ogle; A R Rosenberg; G Kainer
Journal:  Pediatr Nephrol       Date:  1992-09       Impact factor: 3.714

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.